CNBX Pharmaceuticals CNBX
OTC CNBX
$0.00 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

CNBX Pharmaceuticals Inc. (CNBX) Asset Utilization Ratio (2016 - 2024)

CNBX Pharmaceuticals' (CNBX) quarterly Asset Utilization Ratio came in at 1.51 in Q4 2024, up 34.29% YoY from 1.13 in Q4 2023, and down 35.17% on a QoQ basis from 2.34 in Q3 2024.

CNBX Pharmaceuticals Inc. (CNBX) Asset Utilization Ratio (2016 - 2024) Analysis & Trends

CNBX Pharmaceuticals (CNBX) has 9 years of Asset Utilization Ratio data on file, last reported at 1.51 in Q4 2024.

  • Quarterly Asset Utilization Ratio rose 34.29% year-over-year to 1.51 in Q4 2024, while the trailing twelve-month figure through Nov 2024 was 1.51 (up 34.29% YoY) and the FY2024 annual result came in at 0.49, down 21.67% from the prior year.
  • Asset Utilization Ratio eased to 1.51 in Q4 2024, from 2.34 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 2.34 in Q3 2024 to a low of 0.0 in Q2 2021.
  • A 5-year average of 0.64 and a median of 0.05 in 2022 frame the typical range for Asset Utilization Ratio.
  • Annual changes were most pronounced in 2021 — Asset Utilization Ratio tumbled 67.32% — and 2024, when it jumped 3404.99%.
  • Tracing CNBX's Asset Utilization Ratio over 5 years: stood at 0.0 in 2020, then sank by 81.75% to 0.0 in 2021, then surged by 8278.02% to 0.04 in 2022, then jumped by 2572.74% to 1.13 in 2023, then surged by 34.29% to 1.51 in 2024.
  • The last three Asset Utilization Ratio figures came in at 1.51 (Q4 2024), 2.34 (Q3 2024), and 1.89 (Q2 2024), per Business Quant data.

Peer Comparison

Historic Data

Download Data
DateValue
Nov 30, 2024 1.51
Aug 31, 2024 2.34
May 31, 2024 1.89
Feb 29, 2024 1.96
Nov 30, 2023 1.13
Aug 31, 2023 0.71
May 31, 2023 0.61
Feb 28, 2023 0.06
Nov 30, 2022 0.04
Aug 31, 2022 0.03
May 31, 2021 0.00
Feb 28, 2021 0.00
Nov 30, 2020 0.00
Aug 31, 2020 0.00
May 31, 2020 0.00
Feb 29, 2020 0.00
Nov 30, 2019 0.00
Aug 31, 2019 0.00
May 31, 2019 0.00
Feb 28, 2019 0.00